Robert A Ritzel - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Biochemistry|October 9, 2009

Annexin A5 directly interacts with amyloidogenic proteins and reduces their toxicitySahar Bedrood, Sajith Jayasinghe, Derek Sieburth, et al.

The Journal of Clinical Endocrinology and Metabolism|March 6, 2008

Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axisJan Frystyk, Robert A Ritzel, J Maubach, et al.

Diabetes, Obesity & Metabolism|July 14, 2018

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairmentF Javier Escalada, Serge Halimi, Peter A Senior, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Biochemistry|October 9, 2009

Annexin A5 directly interacts with amyloidogenic proteins and reduces their toxicitySahar Bedrood, Sajith Jayasinghe, Derek Sieburth, et al.

The Journal of Clinical Endocrinology and Metabolism|March 6, 2008

Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axisJan Frystyk, Robert A Ritzel, J Maubach, et al.

Diabetes, Obesity & Metabolism|July 14, 2018

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairmentF Javier Escalada, Serge Halimi, Peter A Senior, et al.

Pageof 2